UnknownPhase 2NCT05131386

Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas

Studying OBSOLETE: Pleomorphic undifferentiated sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Grupo Espanol de Investigacion en Sarcomas
Principal Investigator
Andrés Redondo
Hospital Universitario La Paz
Intervention
Trabectedin(drug)
Enrollment
85 enrolled
Eligibility
16-75 years · All sexes
Timeline
20212024

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05131386 on ClinicalTrials.gov

Other trials for OBSOLETE: Pleomorphic undifferentiated sarcoma

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Pleomorphic undifferentiated sarcoma

← Back to all trials